Mupirocin Once Weekly Reduces the Incidence of Catheter Exit-Site Infection in Peritoneal Dialysis Patients

Abstract

Get full access to this article

View all access options for this article.

References

Bernardini

, Piraino

, Holley

, Johnson

J.R.

, Lutes

A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the catheter exit site versus cyclic oral rifampin.

Am J Kidney Dis 1996; 27: 695–700.

Thodis

, Bhaskaran

, Pasadakis

, Bargman

J.M.

, Vas

S.I.

, Oreopoulos

D.G.

Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site.

Perit Dial Int 1998; 18: 261–70.

Rao

S.P.

, Oreopoulos

D.G.

Unusual complications of polyurethane PD catheter.

Perit Dial Int 1997; 17: 410–12.

Riu

, Ruitz

C.G.

, Martinez-Vea

, Peralta

, Oliver

J.A.

Spontaneous rupture of polyurethane peritoneal dialysis catheter: A possible deleterious effect of mupirocin ointment.

Nephrol Dial Transplant 1998; 13: 1870–1.

Annigeri

, Conly

, Vas

S.I.

, Dedier

, Prakashan

K.P.

, Bargman

J.M.

Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection.

Perit Dial Int 2001; 21: 554–9.